These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8305785)

  • 21. Candesartan cilexetil: an angiotensin II receptor blocker.
    Stoukides CA; McVoy HJ; Kaul AF
    Ann Pharmacother; 1999 Dec; 33(12):1287-98. PubMed ID: 10630830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin receptor antagonists.
    Wong W; Howes L
    Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Losartan: first of a new class of angiotensin antagonists for the management of hypertension.
    Carr AA; Prisant LM
    J Clin Pharmacol; 1996 Jan; 36(1):3-12. PubMed ID: 8932538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive therapy targeted to the needs of the patient: focus on the renin-angiotensin system; older and newer agents.
    Itskovitz HD
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 23-8. PubMed ID: 7634560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 28. Rationale for the chemical development of angiotensin II receptor antagonists.
    Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
    Pichler M; Klein W; Huber K; Pachinger O
    Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.
    Burrell LM; Johnston CI
    Drugs Aging; 1997 Jun; 10(6):421-34. PubMed ID: 9205848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-peptide antagonists to angiotensin II receptors. A review].
    Schambye HT; Hjorth SA; Schwartz TW
    Ugeskr Laeger; 1993 Nov; 155(44):3558-62. PubMed ID: 8236577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure.
    Awan NA; Mason DT
    Am Heart J; 1996 Jan; 131(1):177-85. PubMed ID: 8554006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preclinical basis of the therapeutic evaluation of losartan.
    Timmermans PB; Wong PC; Chiu AT; Smith RD
    J Hypertens Suppl; 1995 Jul; 13(1):S1-13. PubMed ID: 18800450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin receptors: physiology and pharmacology.
    Guthrie GP
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angioedema associated with angiotensin II receptor antagonist losartan.
    Sharma PK; Yium JJ
    South Med J; 1997 May; 90(5):552-3. PubMed ID: 9160080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y; Lefebvre J
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irbesartan treatment in hypertension.
    Brown MJ
    Hosp Med; 1998 Oct; 59(10):808-11. PubMed ID: 9850301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
    Pitt B; Chang P; Timmermans PB
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.